Bayer to buy VC-backed vitamin company Care/of: Bloomberg
Bayer has agreed to acquire vitamin company Care/of, reported Bloomberg. The news outlet noted that the transaction will put Care/of at a $225 million valuation.
1 September 2020•1 min read
Bayer has agreed to acquire vitamin company Care/of, reported Bloomberg. The news outlet noted that the transaction will put Care/of at a $225 million valuation.
